advertising
Link to jump to start of content The Seattle Times Company Jobs Autos Homes Rentals NWsource Classifieds seattletimes.com
The Seattle Times Business & Technology
Traffic | Weather | Your account Movies | Restaurants | Today's events

News, analysis and perspectives from the
technology team at The Seattle Times.
Have a news tip? Follow the links below to e-mail us.

All blogs and discussions:

Go

February 27, 2006

How a board says we've earned it

Posted by Benjamin J. Romano at 11:07 AM

Cell Therapeutics' board of directors must think it's doing a great job.

The board of the Seattle biotechnology company voted itself a raise on Feb. 17, according to a regulatory filing today.

Board members approved increases in the initial stock option grant non-employee directors get for joining the board from 15,000 shares to 24,000 shares, but now they vest after a year instead of immediately. Current directors will also get a "make-whole" grant of the difference between the new joining bonus and their initial option grant.

The annual retainer for non-employee directors was also increased from $18,000 to $25,000, and directors who chair committees now get more cash, too.

In addition, three board members were singled out and rewarded with option grants and $9,000 each for "exceptional contributions" to the company during the last two years. Phillip Nudelman received grants to purchase 18,000 shares; Mary Mundinger received 12,000; and Vartan Gregorian, 8,000.

Share:    Digg     Newsvine

Tricia Duryee
Tricia Duryee
E-mail|Bio


Angel Gonzalez
Angel Gonzalez
E-mail|Bio


Kristi Heim
Kristi Heim
E-mail|Bio


Benjamin J. Romano
Benjamin J. Romano
E-mail|Bio


Mark Watanabe
Mark
Watanabe

E-mail|Bio

Marketplace

advertising

advertising